Mesothelioma Clinical Trials Search Tool
Find and explore mesothelioma clinical trials with our easy-to-use search tool and get connected with doctors conducting them. Search by location, trial phase, and specific disease presentation to discover cutting-edge treatment opportunities that may fit your diagnosis.
FILTER BY:
Details
Testing the Addition of Immunotherapy Before Surgery for Patients with Sarcomatoid Mesothelioma
Address: 200 1st St SW, Rochester, MN 55905, USA
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: Yes
- Peritoneal: No
- Pericardial: No
- Tunica Vaginalis: No
- Therapy Targeted: No
Type: Sarcomatoid, Biphasic
Condition: Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma
Description: This phase II trial evaluates the safety and effectiveness of giving immunotherapy (nivolumab and ipilimumab) before surgery for controlling disease in patients with stage I-IIIa sarcomatoid mesothelioma. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving immunotherapy before surgery may be more effective at controlling disease in patients with sarcomatoid mesothelioma than giving immunotherapy alone.
Research Center: Mayo Clinic Rochester
Treatment Interventions: BIOLOGICAL: Nivolumab, BIOLOGICAL: Ipilimumab, PROCEDURE: Surgical Procedure, PROCEDURE: Computed Tomography, PROCEDURE: Magnetic Resonance Imaging, PROCEDURE: Positron Emission Tomography
Clinical Trial Number: NCT05647265
Phase: Phase 2
Status: Recruiting
